Managing discovery in the life sciences : harnessing creativity to drive biomedical innovation
AUTHOR : Rea, Philip A., 1957-
CALL NO : W20.5 R281m 2018
IMPRINT : Cambridge : Cambridge University Press, c2018
In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.
- Provides a combination of theory-based management and economics – the challenges faced by scientists in the research laboratory and the challenges faced by investors in deciding which lines of research in which to invest
- Uses non-technical language to present complex material in a clear and accessible way, including graphs and figures which demonstrate the critical biology
- Debunks some unsupportable or illogical criticisms of the pharmaceutical industry while pursuing the logic of profit-maximizing behavior through the provision of patents to guarantee market exclusivity
